ClinicalTrials.govcontrolled
Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)
ClinicalTrials.gov study NCT02252042. IPD Sharing: YES. Countries: 0. Publications: 5.
ShareScore
32/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 12
- Access
- 4
- Reuse readiness
- 0
- Engagement
- 8